WindRose Health Investors, a private equity firm, has invested in RevHealth, a healthcare communications firm.
With the investment, RevHealth is capable of further growth, drawing on WindRose’s investment experience.
“RevHealth’s deep commitment to clients, impressive scientific acumen, and ability to provide support to clients from early pre-launch through the full drug lifecycle make it uniquely differentiated from other healthcare communications agencies,” said CJ Burnes, partner at WindRose. “We believe RevHealth offers services to its clients and will experience significant growth as the company expands into new logos and services. We are excited to partner with Bruce Epstein, Bruce Medd, Brian Wheeler and their impressive team as they continue to build upon the differentiated platform they have created.”
Guggenheim Securities acted as financial advisor to WindRose, and Houlihan Lokey acted as financial advisor to RevHealth. McDermott Will & Emery LLP acted as legal advisor to WindRose, and DLA Piper LLP acted as legal advisor to RevHealth.